JPMorgan Chase & Co’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.6M | Sell |
|
|||||
|
2025
Q1 | $22.7M | Sell |
|
|||||
|
2024
Q4 | $22.3M | Buy |
|
|||||
|
2024
Q3 | $22.6M | Buy |
|
|||||
|
2024
Q2 | $13M | Buy |
|
|||||
|
2024
Q1 | $6.87M | Sell |
|
|||||
|
2023
Q4 | $9.43M | Buy |
|
|||||
|
2023
Q3 | $3.87M | Sell |
|
|||||
|
2023
Q2 | $7.31M | Buy |
|
|||||
|
2023
Q1 | $2.44M | Sell |
|
|||||
|
2022
Q4 | $3.31M | Buy |
|
|||||
|
2022
Q3 | $1.48M | Buy |
|
|||||
|
2022
Q2 | $954K | Buy |
|
|||||
|
2022
Q1 | $1.64M | Sell |
|
|||||
|
2021
Q4 | $14.9M | Buy |
|
|||||
|
2021
Q3 | $7.6M | Sell |
|
|||||
|
2021
Q2 | $19.5M | Sell |
|
|||||
|
2021
Q1 | $15.1M | Sell |
|
|||||
|
2020
Q4 | $14.2M | Sell |
|
|||||
|
2020
Q3 | $15.9M | Sell |
|
|||||
|
2020
Q2 | $14.8M | Sell |
|
|||||
|
2020
Q1 | $6.23M | Buy |
|
|||||
|
2019
Q4 | $1.82M | Sell |
|
|||||
|
2019
Q3 | $3.39M | Sell |
|
|||||
|
2019
Q2 | $6.69M | Buy |
|
|||||
|
2019
Q1 | $3.53M | Buy |
|
|||||
|
2018
Q4 | $1.1M | Sell |
|
|||||
|
2018
Q3 | $2.48M | Buy |
|
|||||
|
2018
Q2 | $461K | Buy |
|
|||||
|
2018
Q1 | $20K | Sell |
|
|||||
|
2017
Q4 | $4.26M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $96K | Sell |
|
|||||
|
2017
Q1 | $118K | Sell |
|
|||||
|
2016
Q4 | $233K | Buy |
|
|||||
|
2016
Q3 | $45K | Buy |
|